On April 8, 2024, Seres Therapeutics, Inc announced that it has held its annual general meeting of shareholders on April 4, 2024, and declared voting results. Accordingly, a stockholder proposal on simple majority vote from Kenneth Steiner was approved by the shareholders of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.614 USD | -28.03% | -38.60% | -56.14% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.14% | 92.99M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.21B | |
+3.23% | 22.78B | |
-10.44% | 17.96B | |
-41.74% | 16.43B | |
-13.31% | 16.37B | |
+2.44% | 13.58B | |
+27.89% | 11.66B |
- Stock Market
- Equities
- MCRB Stock
- News Seres Therapeutics, Inc.
- Declaration of Voting Results by Seres Therapeutics